Larvol Delta - Updates-in-Newly-Diagnosed-and-RelapsedRefractory-Multiple-Myeloma-from-ASH-2021--Episode-7-Triplet-or-Quadruplet-Therapy-in-TransplantIneligible-NDMM

Darzalex IV (daratumumab) - J&J

Decadron (dexamethasone) - Merck (MSD)

Cyrevia (cyclophosphamide high dose) - Accentia

https://www.onclive.com/view/triplet-or-quadruplet-therapy-in-transplant-ineligible-ndmm

Feb 4, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next